CLINICAL_TRIALS
trial_result
· 2024-11-29
Clinical Trial Update: Dose-finding Study of MR-130A-01 Contraceptive Transdermal Patch [Phase 2]
Summary
The document summarizes completed Phase 2 dose-finding results for MR-130A-01 Contraceptive Transdermal Patch sponsored by Mylan.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Mylan Pharmaceuticals Inc | Conditions: Contraception | Phase 2 | Status: COMPLETED